Nova Eye Medical (EYE) Discussion, page-2152

Well we already have the US sales numbers which makes up the majority of total sales. Those were very impressive despite the LCD. Nothing special is expected for global ex USA as they're not focused on that market yet, so any growth there would be quite bullish. The bottom line figure will be of interest, not sure the market is expecting profitability yet (otherwise the price would be much higher) so that may surprise if it is close to breakeven or even profitable.

I'd say it's most likely going to surprise to the upside as the market really isn't pricing in much. We've got a 2x revenue multiple which is incredibly low compared to peers, they could record zero growth and it would still look cheap. I'd say what the market wants to see is confirmation they won't need to raise capital. If there's an indication they'll need to raise that may be negative, but I sense if they record a strong bottom line figure that'll remove any doubt in the mind of the market and will be the key to releasing the brakes.

I'm quite content in the fact they've brought forward (quite significantly) the release of these results. Their eagerness to show off the numbers to the market isn't for no reason...